Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion type Assertion NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_head.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion description "[As an inhibitor of AKT2, miR-184 could be of potential benefit in miRNA mediated therapeutics of MYCN amplified neuroblastoma and other forms of cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_provenance.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion evidence source_evidence_literature NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_provenance.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion SIO_000772 20409325 NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_provenance.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion wasDerivedFrom befree-2016 NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_provenance.
- NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_assertion wasGeneratedBy ECO_0000203 NP807428.RA4KqkIoov654EF0a5Jn0UXWxG04586jL_UF01GjY-j1Y130_provenance.